Cite
Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faeciumIsolates with or without Reduced Susceptibility to Daptomycin in an In VitroPharmacokinetic/Pharmacodynamic Model
MLA
Belley, Adam, et al. “Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus FaeciumIsolates with or without Reduced Susceptibility to Daptomycin in an In VitroPharmacokinetic/Pharmacodynamic Model.” Antimicrobial Agents and Chemotherapy, vol. 62, no. 1, Oct. 2017. EBSCOhost, https://doi.org/10.1128/AAC.01873-17.
APA
Belley, A., Arhin, F. F., & Moeck, G. (2017). Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faeciumIsolates with or without Reduced Susceptibility to Daptomycin in an In VitroPharmacokinetic/Pharmacodynamic Model. Antimicrobial Agents and Chemotherapy, 62(1). https://doi.org/10.1128/AAC.01873-17
Chicago
Belley, Adam, Francis F. Arhin, and Greg Moeck. 2017. “Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus FaeciumIsolates with or without Reduced Susceptibility to Daptomycin in an In VitroPharmacokinetic/Pharmacodynamic Model.” Antimicrobial Agents and Chemotherapy 62 (1). doi:10.1128/AAC.01873-17.